The Ras family of GTPases in cancer cell invasion

Cellular and Molecular Life Sciences

Volumn 57, Issue 1, 2000, Pages 65-76

  Hernandez Alcoceba R ^a   Del Peso, L ^a   Lacal, J C ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Adhesion; Apoptosis; Cytoskeleton; Invasion; Metastasis; Ras; Rho

Indexed keywords

GUANOSINE TRIPHOSPHATASE; RAS PROTEIN; RHO KINASE;

APOPTOSIS; CANCER INVASION; CELL ADHESION; CYTOSKELETON; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; PROTEIN DEGRADATION; REVIEW;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL MOVEMENT; CYTOSKELETON; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; RAS PROTEINS;

EID: 0033954864     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050499     Document Type: Review

References (133)

1. 1 Kumar V., Cotran R. S. and Robbins S. L. (1997) Neoplasia. In: Basic Pathology, 6th edn, pp. 531-580, Saunders, St. Louis, Mo
2. 2 Lacal J. C. and Tronick S. R. (1988) The ras oncogcnc. In: The Oncogene Handbook, pp. 255-304, 535-550, Reddy E. P., Skalka A. M. and Curran T. (eds), Elsevier, Amsterdam
3. 3 Cuadraro A., Carnero A. and Lacal J. C. (1993) ras-p21 proteins: switch devices for signal transduction. In: The ras Superfamily of GTPases, pp. 119-153, Lacal J. C. and McCormick F. (eds), CRC, Boca Raton, Fla
4. 4 Grand R. J. A. and Owen D. (1991) The biochemistry of ras p21. Biochem. J. 279: 609-631
5. 5 Casey P. J., Solski P. A., Der C. J. and Buss J. E. (1989) p21 ras is modified by a farnesyl isoprenoid. Proc. Natl. Acad. Sci. USA 86: 8323-8327
6. 6 Cox A. D., Hisaka M. M., Buss J. E. and Der C. J. (1992) Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein. Mol. Cell. Biol. 12: 2606-2615
7. 7 Morrison D. K., Kaplan D. R., Rapp U. R. and Roberts T. M. (1988) Signal transduction from membrane to cytoplasm: growth factors and membrane bound oncogene products increase phosphorylation and associated kinase activity. Proc. Nat. Acad. Sci. USA 85: 8855-8859
8. 8 Gale N. W., Kaplan S., Lowenstein E. J., Schlessinger J. and Bar-Sagi D. (1993) Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on ras. Nature 363: 88-92
9. 9 Rozakis-Adcock M., Fernley R., Wade J., Pawson T. and Bowtell D. (1993) The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the ras activator mSos1. Nature 363: 83-85
10. 10 Egan S. E., Giddins B. W., Brooks M. W., Buday L., Sizelan A. M. and Weinber R. A. (1993) Asociation of Sos ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363: 45-51
11. 11 Aelst L. V., Barr M., Marcus S., Polverino A. and Wigler M. (1993) Complex formation between ras and raf and other protein kinases. Proc. Nat. Acad. Sci. USA 90: 6213-6217
12. 12 Troppmair J., Bruder J. T., App H., Cai H., Liptak L., Szeberényi J. et al. (1992) Ras controls coupling of growth factor receptors and protein kinase C in the membrane to raf-1 and B-raf protein serine kinascs in the cytosol. Oncogene 7: 1867-1873
13. 13 Moodie S. A., Willumsen B. M., Weber M. J. and Wolfman A. (1993) Complexes of ras-GDP with raf-1 and the mitogen activated protein kinase kinase. Science 260: 1658-1660
14. 14 Hofer F., Fields S., Schneider C. and Martin G. S. (1994) Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc. Natl. Acad. Sci. USA 91: 11089-11093
15. 15 Kikuchi A., Demo S. D., Ye Z. H., Chen Y. W. and Wiliams L. T. (1994) ralGDS family members interact with the effector loop of ras p21. Mol. Cell. Biol. 14: 7483-7491
16. 16 Rodriguez-Viciana P., Warne P. H., Dhand R., Vanhaesebroeck B., Gout I., Fry M. J. et al. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527-532
17. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358: 414-417
18. 18 Burgering B. M. T. and Coffer P. J. (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602
19. 19 Jiang H., Luo J. Q., Urano T., Frankel P., Lu Z., Foster D. A. et al. (1995) Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 378: 409-412
20. 20 Takai Y., Takuya S., Tanaka K. and Nakanishi H. (1995) Rho as a regulator of the cytoskeleton. Trends Biochem. Sci. 20: 227-231
21. 21 Van Aelst L. and D'Souza-Schorey C. (1997) Rho GTPases and signaling networks. Genes Dev. 11: 2295-2322
22. 22 Perona R., Esteve P., Jiménez B., Ballestero R. P. and Lacal J. C. (1993) Tumorigenic activity of rho genes from Aplysia californica. Oncogene 8: 1285-1292
23. 23 Khosravi-far R., Solski P. A., Clark G. J., Kinch M. S. and Der C. J. (1995) Activation of Rac1, RhoA. and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15: 6443-6453
24. 24 Prendergast G. C., Khosravi-Far R., Solski P. A., Kurzawa H., Lebowitz P. F. and Der C. J. (1995) Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 10: 2289-2296
25. 25 Qiu R. G., Chen J., Kirn D., McCormick F. and Symons M. (1995) An essential role for Rac in Ras transformation. Nature 374: 457-459
26. 26 Perona R., Montaner S., Saniger L., Sanchez-Perez I., Bravo R. and Lacal J. C. (1997) Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11: 463-475
27. 27 Montaner S., Perona R., Saniger L. and Lacal J. C. (1998) Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases. J. Biol. Chem. 273: 12779-12785
28. 28 Hill C. S., Wynne J. and Treisman R. (1995) The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81: 1159-1170
29. 29 Montaner S., Perona R., Saniger L. and Lacal J. C. (1999) Activation of serum response factor by RhoA is mediated by the NF-KB and C EBP transcription factors. J. Biol. Chem. 274: 8506-8515
30. 30 Woodhouse E. C., Chuaqui R. F. and Liotta L. A. (1997) General mechanisms of metastasis. Cancer 80: 1529-1537
31. 31 De Vita V., Hellman S. and Rosenberg S. A. (1993) Principles and Practice of Oncology, 4th edn, Lippincott, Philadelphia
32. 32 Bondy G. P., Wilson S. and Chambers A. F. (1985) Experimental metastatic ability of H-ras-transformed NIH 3T3 cells. Cancer Res. 45: 6005-6009
33. 33 Muschel R. J., Williams J. E., Lowy D. R. and Liotta L. A. (1985) Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. Am. J. Pathool. 121: 1-8
34. 34 Tatsuka M., Ota T., Yamagishi N., Kashihara Y., Wada M., Matsuda N. et al. (1996) Different metastatic potentials of ras-and src-transformed BALB/c 3T3 A31 cells. Mole. Carcinogenesis 15: 300-308
35. 35 Ballin M., Mackay A. R., Hartzler J. L., Nason A., Pelina M. D. and Thorgeirsson U. P. (1991) Ras levels and metalloproteinase activity in normal versus neoplastic ras mammary tissues. Clin. Exp. Metastasis 9: 179-189
36. 36 Price J. E., Aukerman S. L., Ananthaswamy H. N., McIntyre B. W., Schackert G., Schackert H. K. et al. (1989) Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras. Cancer Res. 49: 4274-4281
37. 37 Wallace J. S., Hayle A. J., Syms A. J., Cairney M., Tutty B., Gazzard A. et al. (1989) The ras oncogene and tumor metastasis: observations on murine cells transfected with activated human c-Ha-ras. Differentiation 41: 208-215
38. 38 Peso L. del, Hernandez-Alcoceba R., Embade N., Carnero A., Esteve P., Paje C. et al. (1997) Rho proteins induce metastatic properties in vivo. Oncogene 15: 3047-3057
39. 39 Wyllie A. H., Rose K. A., Morris R. G., Steel C. M., Foster E. and Spandidos D. A. (1987) Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br. J. Cancer 56: 251-259
40. 40 Ichikawa T., Kiprianou N. and Isaacs J. T. (1990) Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection. Cancer Res. 50: 6349-6357
41. 41 Ichikawa T., Schalken J. A., Ichikawa Y., Steinberg G. D. and Isaacs J. T. (1991) H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostalic cancer cells following v-H-ras oncogene transfection. Prostate 18: 163-172
42. 42 Vousden K. H., Eccles S. A., Purvies H. and Marshall C. J. (1986) Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c-Ha-ras-1 gene. Int. J. Cancer 37: 425-433
43. 43 Suchy B., Zietz C. and Rabes H. M. (1992) K-ras point mutations in human colorectal carcinomas: relation to aneuploidy and metastasis. Int. J. Cancer 52: 30-33
44. 44 Michelassi F., Erroi F., Roncella M. and Block G. E. (1989) Ras oncogene and the acquisition of metastasizing properties by rectal adenocarcinoma. Dis. Colon Rectum 32: 665-668
45. 45 Garzetti G. G., Ciavattini A., Lucarini G., Goteri G., Nictolis M. D., Romanini C. et al. (1998) Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index. Anticancer Res. 18: 609-613
46. 46 Shekhar P. V. and Miller F. R. (1994) Correlation of differences in modulation of ras expression with metastatic competence of mouse mammary tumor subpopulations. Invasion Metastasis 14: 27-37
47. 47 Lundy J, Grimson R., Mishriki Y., Chao S., Ovarez S., Fromowitz F. et al. (1986) Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients. J. Clin. Oncol. 4: 1321-1325
48. 48 Deng G. R., Liu X. H. and Wang J. R. (1991) Correlation of mutations of oncogene c-Ha-ras at codon 12 with metastasis and survival of gastric cancer patients. Oncogene Res. 6: 33-38
49. 49 Ballestero R. P., Esteve P., Perona R., Jiménez B. and Lacal J. C. (1991) Biological function of Aplysia californica rho gene. In: The Superfamily of ras Related Genes, pp. 237-242, NATO Advanced Science Institute Series, vol. A220, Plenum, New York.
50. 50 Suwa H., Ohshio G., Imamura T., Watanabe G., Arii S., Imamura M. et al. (1998) Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br. J. Cancer 77: 147-152
51. 51 Roux P., Gauthier-Rouviere C., Doucel-Brutin S. and Fort P. (1997) The small GTPases Cdc42Hs, Rac1 and RhoG delineate Raf-independent pathways that cooperate to transform NIH3T3 cells. Curr. Biol. 7: 629-637
52. 52 Habets G. G. M, Scholtes E. H. M., Zuydgeest D., Kammen R. A. v. d., Stam J. C., Berns A. et al. (1994) Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77: 537-549
53. 53 Michiels F., Habets G. G. M., Stam J. C., van der Kammen R. A. and Collard J. G. (1995) A role for Rac in Tiam1-in-duced membrane ruffling and invasion. Nature 375: 338-340
54. 54 Keely P. J., Westwick J. K., Whitehead I. P., Der C. J. and Parise L. V. (1997) Cdc42 and Rac1 induce integrin-mediated cell molility and invasiveness through PI(3)K. Nature 390: 632-636
55. 55 Kozma R., Ahmed S., Best A. and Lim L. (1995) The Ras-related protein Cdc42Hs and brudykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. Mol. Cell. Biol. 15: 1942-1952
56. 56 Nobes C. D. and Hall A. (1995) Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81: 53-56
57. 57 Renshaw M. W., Toksoz D. and Schwartz M. A. (1996) Involvement of the small GTPase rho in integrin-mediated activation of mitogen-activated protein kinase., J. Biol. Chem. 271: 21691-21694
58. 58 Keely P., Parise L. and Juliano R. (1998) Integrins and GTPases in tumour cell growth, motility and invasion. Trends Cell Biol. 8: 101-106
59. 59 Clark E. A., King W. G., Brugge J. S., Symons M. and Hynes R. O. (1998) Integrin-mediated signals regulated by members of the rho family of GTPases. J. Cell. Biol. 142: 573-586
60. 60 Sharma S. V. (1998) Rapid recruitment of p120RasGAP and its associated protein, p190RhoGAP, to the cytoskeleton during integrin mediated cell-substrate interaction. Oncogene 17: 271-281
61. 61 D'Souza-Schorey C., Boettner B. and Van Aelst L. (1998) Rac regulates integrin-mediated spreading and increased adhesion of T lymphocytes. Mol. Cell. Biol. 18: 3936-3946
62. 62 Nakahara H., Mueller S. C., Nomizu M., Yamada Y., Yeh Y. and Chen W. T. (1998) Activation of beta1 integrin stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protusive activities at invadipodia. J. Biol. Chem. 273: 9-12
63. 63 Tokman M. G., Porter R. A. and Williams C. L. (1997) Regulation of cadherin-mediated adhesion by the small GTP-binding protein Rho in small cell lung carcinoma cells. Cancer Res. 57: 1785-1793
64. 64 Kuroda S., Fukata M., Nakagawa M., Fujii K., Nakamura T., Ookubo T. et al. (1998) Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin-mediated cell-cell adhesion. Science 281: 832-835
65. 65 Kuroda S., Fukata M., Fujii K., Nakamura T., Izawa I. and Kaibuchi K. (1997) Regulation of cell-cell adhesion of MDCK cells by Cdc42 and Rac1 small GTPases. Biochem. Biophys. 240: 430-435
66. 66 Horkijk P. L., Klooster J. P . ten, Kammen R. A. van der, Michelis F., Oomen L. C. and Collard J. G. (1997) Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 278: 1464-1466
67. 67 Hofmann M., Rudy W., Gunthert U., Zimmer S. G., Zawadzki V., Zoller M. et al. (1993) A link between ras and metastatic behaviour of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res. 53: 1516-1521
68. 68 Potempa S. und Ridley A. J. (1998) Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepalocyte growth factor/scatter factor-induced adherens junction disassembly. Mol. Biol. Cell. 9: 2185-2200
69. 69 Giordano S., Bardelli A., Zhen Z , Menard S., Ponzetto C. and Comoglio P. M. (1997) A point mutation in the MET oncogene abrogates metastasis without affecting transformation. Proc. Natl. Acad. Sci. USA 94: 13868-13872
70. 70 To C. T. and Tsao M. S. (1998) The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers. Oncol. Rep. 5: 1013-1024
71. 71 Anand-Apte B., Zetter B. R., Viswanathan A., Qiu R. G., Chen J., Ruggieri R. et al. (1997) Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by Rac and extracellular signal-regulated kinase pathways. J. Biol. Chem. 272: 30688-30692
72. 72 Kundra V., Anand-Apte B., Feig L. A. and Zetter B. R. (1995) The chemotactic response to PDGFBB: evidence of a role for Ras. J. Cell Biol. 130: 725-731
73. 73 Klemke R. L., Cai S., Giannini A. L., Gallagher P. J., de Lanerolle P. and Cheresh D. A. (1997) Regulation of cell motilily by mitogen-activated protein kinase. J. Cell Biol. 137:481-492
74. 74 Kureishi Y., Kobayashi S., Amano M., Kimura K., Kanaide H. and Nakano T. et al. (1997) Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. 272: 12257-12260
75. 75 Yoshioka K., Matsumura F., Akedo H. and Itoh K. (1998) Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J. Biol. Chem. 273: 5146-5154
76. 76 Di Cristofano A., Pesce B., Cordon-Cardo C. and Pandolfi P. P. (1998) Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19: 348-355
77. 77 Maehama T. and Dixon J. E. (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273: 13375-13378
78. 78 Han J, Luby-Phelps K., Das B., Shu X., Xia Y., Mosteller R. D. et al. (1998) Role of substrates and products of PI 3-kinase in regulating activation of Rac-relaled guanosine triphosphatases by Vav. Science 279: 558-560
79. 79 Tamura M., Gu J., Matsumoto K., Aota S., Parsons R. and Yamada K. M. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614-1617
80. 80 Koop S., Schmidt E. F., MacDonald I. C., Morris V. L., Khokha R., Grattan M. et al. (1996) Independence of metastatic ability and extravasation: metastalic ras-transformed and control fibroblasts extravasate equally well. Proc. Natl. Acad. Sci. USA 93: 11080-11084
81. 81 Luzzi K. J., MacDonald I. C., Schmidt E. E., Kerkvliet N., Morris V. L., Chambers A. F. et al. (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after succesful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153: 865-873
82. 82 Weber K. S., Klickstein L. B., Weber P. C. and Weber C. (1998) Chemokine-induced monocyte transmigration requires cdc42-mediated cytoskeletal changes. Eur. J. Immunol. 28: 2245-2251
83. 83 Sandig M., Voura E. B., Kalnins V. I. and Siu C. H. (1997) Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell Motil. Cytoskeleton 38: 351-364
84. 84 Himelstein B. P., Canete-Soler R., Bernhard E. J. and Muschel R. J. (1994) Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J. Cell Sci. 107: 477-486
85. 85 Giambernardi T. A., Grant G. M., Taylor G. P., Hay R. J., Maher V. M., McCormick J. J. et al. (1988) Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol. 16: 483-496
86. 86 Yanagihara K., Nii M., Tsumuraya M., Numoto M., Seito T. and Seyama T. (1995) A radiation-induced murine ovarian granulosa cell tumor line: introduction of v-ras gene potentiates a high metastatic ability. Jpn. J. Cancer Res. 86: 347-356
87. 87 Graff J. R., Boghaert E. R., De Benedetti A., Tudor D. L., Zimmer C. C., Chan S. K. et al. (1995) Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned embryo fibroblasts. Int. J. Cancer 60: 255-263
88. 88 Ballin M., Gomez D. E., Sinha C. C. and Thorgeirsson U. P. (1988) Ras oncogene mediated induction of a 92 kDa metalloproteinase: strong correlation with the malignant phenotype. Biochem. Biophys. Res. Commun. 154: 832-838
89. 89 Himelstein B. P., Lee E. J., Sato H., Seiki M. and Muschel R. J. (1997) Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 14: 1995-1998
90. 90 Bernhard E. J., Hagner B., Wong C., Lubenski I. and Muschel R. J. (1995) The effect of E1A transfection on MMP-9 expression and metastatic potential. Int. J. Cancer 60: 718-724
91. 91 Chambers A. and Tuck A. (1993) Ras-responsive genes and tumor metastasis. Crit. Rev. Oncog. 4: 95-114
92. 92 Reich R., Blumenthal M. and Liscovitch M. (1995) Role of phospholipase D in laminin-induced production of gelatinasc A (MMP-2) in metastatic cells. Clin. E.xp. Metastasis 13: 134-140
93. 93 Williger B.-T., Reich R., Neeman M., Bercovici T. and Liscovitch M. (1995) Release of gelatinase A (matrix metalloproteinase 2) induced by photolysis of caged phosphatidic acid in HT 1080 metastatic fibrosarcoma cells. J. Biol. Chem. 270: 29656-29659
94. 94 Bowman E. P., Uhlinger D. J. and Lambeth J. D. (1993) Neutrophil phospholipase D is activated by a membrane-associated Rho family small molecular weight GTP-binding protein. J. Biol. Chem. 268: 21509-21512
95. 95 Malcolm K. C., Ross A. H., Qiu R. G., Symons M. and Exton J. H. (1994) Activation of rat liver phospholipase D by the small GTP-binding protein RhoA. J. Biol. Chem. 269: 25951-25954
96. 96 Carnero A., Cuadraro A., del Peso L. and Lacal J. C. (1994) Activation of type D phospholipase by scrum stimulation and ras-induced transformation in NIH 3T3 cells. Oncogene 9: 1387-1395
97. 97 Jiang H., Lu Z., Luo J.-Q., Wolfman A. and Foster D. A. (1995) Ras mediates the activation of phospholipase D by v-Src. J. Biol. Chem. 270: 6006-6009
98. 98 Peso L. del, Lucas L., Esteve P. and Lacal J. C. (1997) Activation of phospholipase D by growth factors and oncogenes in murine fibroblast follow alternative but cross-talking pathways. Biochem. J. 322: 519-528
99. 99 Peso L. del, Hernández R., Esteve P. and Lacal J. C. (1996) Activation of phospholipase D by Ras proteins is independent of protein kinase C. J. Cell. Biochem. 61: 599-608
100. 100 Yamamoto H., Itoh F., Senota A., Adachi Y., Yoshimoto M., Endoh T. et al. (1995) Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells. J. Clin. Lab. Anal. 9: 297-301
101. 101 Brunner G., Pohl J., Erkell L. J., Radler-Pohl A. and Schirrmacher V. (1989) Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of activated Ha-ras oncogene. J. Cancer. Res. Clin. Oncol. 115: 139-144
102. 102 Paciucci R., Tora M., Diaz V. M. and Real F. X. (1998) The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene 16: 625-633
103. 103 Silberman S., Janulis M. and Schultz R. M. (1997) Characterization of downstream Ras signals that induce alternative protease-dependent invasive phenotypes. J. Biol. Chem. 272: 5927-5935
104. 104 Zhang J. Y. and Schultz R. M. (1992) Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation. Cancer Res. 52: 6682-6689
105. 105 Su Z. Z., Austin V. N., Zimmer S. G. and Fisher P. B. (1993) Defining the critical gene expression changes associated with expression and suppression of the lumorigenic and metastatic phenotype in Ha-ras-transformed rat embryo fibroblast cell. Oncogene 8: 1211-1219
106. 106 Chambers A. F., Colella R., Denhardi D. T. and Wilson S. M. (1992) Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NTH 3T3 cells. Mol. Carcinogenesis 5: 238-245
107. 107 Larcher F., Robles A. I., Duran H., Murillas R., Quintanilla M., Cano A. et al. (1996) Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res. 56: 5391-5396
108. 108 Steeg P. S., Bevilacqua G., Pozzalti R., Liotia L. A. and Sobel M. E. (1988) Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res. 48: 6550-6554
109. 109 Pozzati R., McCormick M., Thompson M. A. and Khoury G. (1998) The E1a gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells. Mol. Cell. Biol. 8: 2984-2988
110. 110 Garbisa S., Pozzati R., Muschel R. J., Saffiotti U., Ballin M., Goldfarb R. H. et al. (1987) Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res. 47: 1523-1528
111. 111 Shibata K., Kikkawa F., Nawa A., Thant A. A., Naruse K., Mizutani S. et al. (1998) Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res. 58: 900-903
112. 112 Raff M. C. (1992) Social controls on cell survival and cell death. Nature 356: 397-400
113. 113 Raff M. C., Barres B. A.. Burne J. F., Coles H. S., Ishizaki Y. and Jacobson M. D. (1993) Programmed cell death and control of cell survival: lessons from nervous system. Science 262: 695-700
114. 114 Jacobson D., Weil M. and Raff M. (1997) Programmed cell death in animal development. Cell 88: 347-354
115. 115 Rudin C. M. and Thompson C. B. (1997) Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu. Rev. Med. 48: 267-281
116. 116 Kerr J. F., Winterford C. M. and Harmon B. V. (1994) Apoptosis: its significance in cancer and cancer therapy. Cancer 73: 2013-2026
117. 117 Tsujimoto Y., Finger L. R., Yunis J., Nowell P. C. and Croce C. M. (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226: 1097-1099
118. 118 Cleary M. L., Smith S. D. and Sklar J. (1986) Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/ immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47: 19-28
119. 119 Bakhshi A., Jensen J. P., Goldman P., Wright J. J., McBride O. W., Epstein A. L. et al. (1985) Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41: 899-906
120. 120 Ruoslahti E. and Reed J. C. (1994) Anchorage dependence, integrins, and apoplosis. Cell 77: 477-478
121. 121 Frisch S. M. and Francis H. (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124: 619-626
122. 122 Meredith J. E., Fazeli B. and Schwartz M. A. (1993) The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4: 953-961
123. 123 Khwaja A., Rodriguez-Viciana P., Wennstrom S., Warne P. H. and Downward J. (1997) Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16: 2783-2793
124. 124 Evan G. and Littlewood T. (1998) A matter of life and cell death. Science 281: 1317-1322
125. 125 Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M. et al. ( 1992) Induction of apoplosis in fibroblasts by c-myc protein. Cell 69: 119-128
126. 126 Shi Y., Glynn J. M., Guilbert L. J., Cotter T. G., Bissonnette R. P. and Green D. R. (1992) Role for c-myc in activation-induced apoptolic cell death in T cell hybridomus. Science 257: 212-214
127. 127 Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J. et al. (I997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548
128. 128 el-Deiry W.S. (1997) Role of oncogenes in resistance and killing by cancer therapeutic agents. Curr. Opin. Oncol. 9: 79-87
129. 129 Jiménez B., Arends M., Esteve P., Perona R., Sánchez R., Ramón y Cajal S. et al. (1995) Induction of apoptosis in NIH 3T3 cells by rho-p21, a GTPase protein of the ras superfamily. Oncogcne 10: 811-816
130. 130 Esteve P., del Peso L. and Lacal J. C. (1995) Induction of apoptosis by rho in NIH 3T3 cells requires competence and progression signals: ceramides function as a progression factor for apoptosis. Oncogene 11: 2657-2665
131. 131 Esteve P., Embade N., Perona R., Jiménez B., León J., Peso L. del et al. (1998) Rho-regulated signals induce apoplosis in vitro and in vivo by a p53-independent, but Bcl2-dependent pathway. Oncogene 17: 1855-1869
132. 132 Lacal J. C. (1997) Regulation of proliferation and apoptosis by Ras and Rho GTPases through specific phospholipid-dependent signaling. FEBS Lett. 410: 73-77
133. 133 Fisher D. E. (1994) Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542